Andere talen Kiniksa Pharmaceuticals, Ltd.

Aandelen

KNSA

BMG5269C1010

Geschatte realtime Cboe BZX Andere beurzen 19:39:27 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
18,1 ^USD	+5,85%		+3,55%	+3,08%

14:37	Kiniksa Pharmaceuticals Q1 Verlies neemt toe, omzet stijgt	MT
14:30	Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	14:37
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Posts Q1 Revenue $79.9M, vs. Street Est of $78.5M	13:36
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution	13:31
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	13:30
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024	16/04
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	02/04
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	02/04
PRACTICE STATEMENT LETTER PROPOSED SCHEME OF ARRANGEMENT IN RESPECT OF: KINIKSA PHARMACEUTICALS, LTD - Form 8-K	29/03
Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase	28/02
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Reports Q4 Revenue $83.4M, vs. Street Est of $72.3M	28/02
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution	28/02
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024	21/02
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for the Year 2024	08/01
Kiniksa Pharmaceuticals Provides Corporate Update	04/01
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference	02/01
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Reports Q3 Revenue $67M, vs. Street Est of $64.4M	31-10-23
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for 2023	31-10-23
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31-10-23
Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution	31-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kiniksa Pharmaceuticals, Ltd.

Aandelen

KNSA

BMG5269C1010

Andere talen

Filters